Matches in Wikidata for { <http://www.wikidata.org/entity/Q78946081> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q78946081 description "1961 թվականի հուլիսի 1-ին հրատարակված գիտական հոդված" @default.
- Q78946081 description "artículu científicu espublizáu en xunetu de 1961" @default.
- Q78946081 description "im Juli 1961 veröffentlichter wissenschaftlicher Artikel" @default.
- Q78946081 description "scientific article published on 01 July 1961" @default.
- Q78946081 description "wetenschappelijk artikel" @default.
- Q78946081 description "наукова стаття, опублікована в липні 1961" @default.
- Q78946081 name "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 name "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 type Item @default.
- Q78946081 label "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 label "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 prefLabel "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 prefLabel "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 P1433 Q78946081-265ED63C-C092-411B-A972-8BB280A85263 @default.
- Q78946081 P1476 Q78946081-A27DF564-D73D-438F-8D69-292F0C0D3ECD @default.
- Q78946081 P2093 Q78946081-239628FF-EFDA-4511-94DF-A9A9210B02B3 @default.
- Q78946081 P2093 Q78946081-3FE5AE22-4735-4D7C-839E-D8918D7F20F3 @default.
- Q78946081 P304 Q78946081-039E551F-07A7-4610-A556-9C6A59645C5D @default.
- Q78946081 P31 Q78946081-C26E1DC0-DD54-4EBF-9AFE-6BA9F8F9F52A @default.
- Q78946081 P478 Q78946081-3B318FA5-1DE7-4DCC-85F8-FCCBF52C37A1 @default.
- Q78946081 P577 Q78946081-32D0AD87-8168-49C0-88C8-9937C811470F @default.
- Q78946081 P698 Q78946081-667DD0B2-DC66-4FF8-AB62-9D1F0792C562 @default.
- Q78946081 P698 13728985 @default.
- Q78946081 P1433 Q27708888 @default.
- Q78946081 P1476 "[Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment.]" @default.
- Q78946081 P2093 "BLUMBERGER K" @default.
- Q78946081 P2093 "NIEPER HA" @default.
- Q78946081 P304 "305-309" @default.
- Q78946081 P31 Q13442814 @default.
- Q78946081 P478 "15" @default.
- Q78946081 P577 "1961-07-01T00:00:00Z" @default.
- Q78946081 P698 "13728985" @default.